Tidal ETF Trust II YieldMax TSLA Option Income Strategy ETF (ARCA: TSLY)

Latest news for Tidal ETF Trust II YieldMax TSLA Option Income Strategy ETF (ARCA:TSLY)

The Fund is an actively managed exchange-traded fund (ETF) that seeks current income while maintaining the opportunity for exposure to the share price (i.e., the price returns) of the common stock of Tesla, Inc. (TSLA), subject to a limit on potential investment gains. The Fund will seek to employ its investment strategy as it relates to TSLA regardless of whether there are periods adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. As further described below, the Fund uses a synthetic covered call strategy to provide income and exposure to the share price returns of TSLA, subject to a limit on potential investment gains as a result of the nature of the options strategy it employs.

First American Government Obligations Fund

YieldMax TSLA Option Income Strategy ETF

Tidal ETF Trust II YieldMax TSLA Option Income Strategy ETF

Stifel analyst Matthew Smith maintains BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) with a Buy and raises the price target from $67 to $81.

News

Price Target

Analyst Ratings

BRBR

Stifel Maintains Buy on BellRing Brands, Raises Price Target to $81

Barclays analyst Jiong Shao maintains Trip.com Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) with a Overweight and raises the price target from $76 to $84.

TCOM

Barclays Maintains Overweight on Trip.com Group, Raises Price Target to $84

WIIM

CHWY

Chewy shares are trading higher after B of A Securities upgraded the stock from Underperform to Buy and raised its price target from $24 to $40.

Stifel analyst Stephen Gengaro downgrades DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) from Buy to Hold and lowers the price target from $16 to $8.

Downgrades

BOOM

Stifel Downgrades DMC Glb to Hold, Lowers Price Target to $8

Benchmark analyst Bruce Jackson reiterates Milestone Scientific (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MLSS#AMEX">MLSS</a>) with a Speculative Buy and maintains $1.25 price target.

Reiteration

MLSS

Benchmark Reiterates Speculative Buy on Milestone Scientific, Maintains $1.25 Price Target

KEYS

Keysight Techs shares are trading higher after the company reported better-than-expected Q4 financial results. Also, multiple firms raised their respective price targets on the stock.

Company growth continues in support of high-performance compute customers
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fcorescientific.com%2F&amp;esheet=54155709&amp;newsitemid=20241120134811&amp;lan=en-US&amp;anchor=Core+Scientific+Inc.&amp;index=1&amp;md5=76f2b34d9aeda6f0fcb62d21ab645f03">Core Scientific Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-performance computing and bitcoin mining, today announced the Denton City Council's approval of amendments to the Company's Power Purchase Agreements and land leases. The approval came during the Council's November 19 meeting.

Core Scientific, Inc. - Class A Common Stock

CORZ

Core Scientific Announces The Denton City Council's Approval Of Amendments To The Company's Power Purchase Agreements And Land Leases

Stifel analyst Selman Akyol maintains Targa Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRGP#NYSE">TRGP</a>) with a Buy and raises the price target from $190 to $224.

TRGP

Stifel Maintains Buy on Targa Resources, Raises Price Target to $224

Needham analyst Ami Fadia reiterates Sage Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) with a Hold.

SAGE

Needham Reiterates Hold on Sage Therapeutics

TVGN

Tevogen Bio Holdings shares are trading higher after the company announced it internally developed an intellectual property portfolio and product assets valued at over $10 billion that does not currently reflect in the balance sheet.

New company to provide world-class news, sports and entertainment with significant scale and resources
Media veterans Mark Lazarus and Anand Kini to lead the new company
Comcast will continue its strategic focus on driving its core growth businesses, including residential broadband, wireless, business services and NBCUniversal's streaming, studios and theme parks
Tax-free transaction expected to be completed in approximately one year
Comcast Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>) today announced its intent to create a new publicly traded company comprised of a strong portfolio of NBCUniversal's cable television networks, including USA Network, CNBC, MSNBC, Oxygen, E!, SYFY and Golf Channel along with complementary digital assets including Fandango and Rotten Tomatoes, GolfNow and Sports Engine, through a tax-free spin-off. The well-capitalized independent company ("SpinCo") will have significant scale as a pure-play set of assets anchored by leading news, sports and entertainment content.
SpinCo will be an industry-leading news, sports and entertainment cable television business with a focused strategic direction. SpinCo's stable of marquee brands will provide a diverse and differentiated content offering that will reach approximately 70 million U.S. households.

CMCSA

Comcast Announces Intention To Create Leading Independent Media Business Through Spin-off Of Select Cable Television Networks; New Company To Provide World-Class News, Sports And Entertainment With Significant Scale And Resources

Earnings

WILC

G. Willi-Food Intl Q3 Sales $41.20M Up From $33.4M YoY

Barclays analyst Theresa Chen maintains TC Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TRP#TSX">TRP</a>) with a Overweight and raises the price target from C$67 to C$74.

TSX:TRP

Barclays Maintains Overweight on TC Energy, Raises Price Target to C$74

HC Wainwright &amp; Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELDN#NASDAQ">ELDN</a>) with a Buy and maintains $16 price target.

ELDN

HC Wainwright & Co. Reiterates Buy on Eledon Pharma, Maintains $16 Price Target

As Thanksgiving approaches, the Last Prisoner Project (LPP) called on President Biden to fulfill his promise that "no one should be in jail for marijuana" by granting clemency to individuals still incarcerated for nonviolent cannabis offenses.
The non-profit cannabis justice reform organization reminded that there's only two months remaining in the <a href="https://www.benzinga.com/markets/cannabis/24/09/40805469/biden-faces-pressure-to-release-thousands-imprisoned-for-federal-cannabis-convictions">#Countdown4Clemency campaign</a>, and that an impending change in administration highlights the urgency for President to take action.
LPP stressed that Biden has <a href="https://www.benzinga.com/markets/cannabis/24/09/40885403/biden-has-not-freed-anyone-in-prison-for-cannabis-crime-last-prisoner-project-urges-president-to">not released a single person</a> still incarcerated for cannabis through commutation. While his <a href="Biden Pardons Thousands Convicted Of Cannabis Possession, Calls On Governors To Do The Same">categorical pardons</a> provided record relief to thousands of people with cannabis possession convictions, this move alone does not address the estimated 3,000 people still serving time in federal prisons for cannabis offenses.
Ahead of the annual presidential tradition of pardoning turkeys, LPP is asking President Biden to #PardonPeopleNotPoultry and end the continued incarceration of thousands for cannabis-related offenses that are now legal in many states.
A YouGov poll released in August indicated that cannabis pardons was one of the most popular policies of Biden's entire administration. Meanwhile, polls show that 84% of registered voters favor releasing people still in prison when their convictions are no longer considered crimes, like cannabis-related offenses.
Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h2 class="wp-block-heading">Governors Took Action</h2>
At the state level, Kansas Governor Laura Kelly was the first to kick off the holiday clemency season granting clemency last week to LPP constituent Deshaun T. Durham, a 24-year-old who was sentenced to 92 months for a first-time cannabis offense, setting a powerful precedent for others to follow. Other recent actions by state leaders like Massachusetts Governor <a href="https://www.benzinga.com/markets/cannabis/24/04/38101290/gov-healeys-mega-pardon-for-cannabis-possession-unanimously-approved-by-council">Maura Healey</a> and Maryland Governor Wes Moore, who used LPP's #PenToRightHistory <a href="https://www.benzinga.com/markets/cannabis/24/06/39357557/maryland-gov-to-pardon-175k-low-level-cannabis-convictions-in-the-nations-most-far-reaching-and-">to pardon over 175,000 individuals</a> for cannabis-related charges, highlight the growing momentum for cannabis clemency.
<h2 class="wp-block-heading">More Still Behind Bars</h2>
Yet, for other Marylanders like Jonathan Wall, incarcerated on an 8-year federal cannabis charge, can only get that type of clemency relief from the president. Then, there's Ricardo Ashmeade, who is serving a 22-year sentence due to the three-strikes law championed by then-Senator Biden. His daughter, Richeda Ashmeade, has been separated from her father for 16 years. In addition to Ricardo, individuals like Edwin Rubis, who is serving a 40-year sentence for a cannabis-related offense, and David Lopez, who has faced years behind bars for court errors on his cannabis charges, exemplify the urgent need for clemency.
Read More: <a href="https://www.benzinga.com/markets/cannabis/24/09/40869663/meet-the-man-serving-a-40-year-sentence-for-non-violent-cannabis-charges-awaiting-pardon-from-bi">Meet The Man Serving A 40-Year Sentence For Non-Violent Cannabis Charges, Awaiting Pardon From Biden</a>
Along with its 420 Unity Coalition partners, LPP will hold a press conference in Washington D.C. next week to encourage people to call President Biden to urge him to reunite these families before the holidays and send letters to the White House to grant cannabis clemency before the end of his term.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/09/41008113/white-house-highlights-marijuana-pardons-amid-skepticism-over-cannabis-rescheduling-efforts">White House Highlights Marijuana Pardons Amid Skepticism Over Cannabis Rescheduling Efforts</a></li>
</ul>
Photo: Benzinga edit Adam Schultz on Wikimedia Commons and David Smart on Shutterstock

Cannabis

President Biden, People Are Still In Jail For Marijuana Despite Your Promise, Cannabis Clemency Advocates Call For Change

Sociedad Quimica Y Minera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQM#NYSE">SQM</a>) reported quarterly earnings of $0.46 per share which missed the analyst consensus estimate of $0.66 by 30.3 percent. This is a 72.62 percent decrease over earnings of $1.68 per share from the same period last year. The company reported quarterly sales of $1.08 billion which missed the analyst consensus estimate of $1.09 billion by 0.93 percent. This is a 41.47 percent decrease over sales of $1.84 billion the same period last year.

Sociedad Quimica Y Minera Q3 EPS $0.46 Misses $0.66 Estimate, Sales $1.08B Miss $1.09B Estimate

B. Riley Securities analyst Dave Kang downgrades Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) from Neutral to Sell and lowers the price target from $194 to $178.

B. Riley Securities Downgrades Fabrinet to Sell, Lowers Price Target to $178

XTKG

X3 Holdings shares are trading lower. The company announced a 1-for-20 reverse stock split.

SLXN

Silexion Therapeutics shares are trading higher after the company announced Guangzhou Sino-Israel bio-industry investment fund reported a 13.8% stake in the company.

Barclays analyst Saket Kalia maintains Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) with a Overweight and raises the price target from $42 to $51.

RBRK

Barclays Maintains Overweight on Rubrik, Raises Price Target to $51

TSLY Provides Investors A Significant Income Alternative

TSLY: How I Try To Avoid The Deadly Covered-Call Mistakes

YieldMax TSLA Option Income Strategy ETF declares $1.0949 dividend

Avoid YMAX: High Fees And Bad Strategy

ULTY: Ignore This Extremely High-Risk Income Trap

Steady Cash Flow Meets Tech Titans: A Look At YMAG

TSLY: A Look At The Pros And Cons Of This Option Income ETF

The six Kurv single-stock covered call ETFs have lower distribution yields, but the stock price charts for the last four-plus months have very positive slopes.

Comments

Tidal ETF Trust II YieldMax TSLA Option Income Strategy ETF

News

Latest news for Tidal ETF Trust II YieldMax TSLA Option Income Strategy ETF (ARCA:TSLY)

Tuesday, February 13, 2024

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga